111 related articles for article (PubMed ID: 9155882)
1. Growth ability of auxiliary gene mutants of human immunodeficiency virus types 1 and 2 in unstimulated peripheral blood mononuclear cells.
Tokunaga K; Ishimoto A; Ikuta K; Adachi A
Arch Virol; 1997; 142(1):177-81. PubMed ID: 9155882
[TBL] [Abstract][Full Text] [Related]
2. Growth ability of human immunodeficiency virus type 1 auxiliary gene mutants in primary blood macrophage cultures.
Kawamura M; Ishizaki T; Ishimoto A; Shioda T; Kitamura T; Adachi A
J Gen Virol; 1994 Sep; 75 ( Pt 9)():2427-31. PubMed ID: 8077944
[TBL] [Abstract][Full Text] [Related]
3. Biological characterization of human immunodeficiency virus type 1 and type 2 mutants in human peripheral blood mononuclear cells.
Akari H; Sakuragi J; Takebe Y; Tomonaga K; Kawamura M; Fukasawa M; Miura T; Shinjo T; Hayami M
Arch Virol; 1992; 123(1-2):157-67. PubMed ID: 1550494
[TBL] [Abstract][Full Text] [Related]
4. Construction of human immunodeficiency virus 1/simian immunodeficiency virus strain mac chimeric viruses having vpr and/or nef of different parental origins and their in vitro and in vivo replication.
Kuwata T; Igarashi T; Ido E; Jin M; Mizuno A; Chen J; Hayami M
J Gen Virol; 1995 Sep; 76 ( Pt 9)():2181-91. PubMed ID: 7561755
[TBL] [Abstract][Full Text] [Related]
5. Vpx and Vpr proteins of HIV-2 up-regulate the viral infectivity by a distinct mechanism in lymphocytic cells.
Ueno F; Shiota H; Miyaura M; Yoshida A; Sakurai A; Tatsuki J; Koyama AH; Akari H; Adachi A; Fujita M
Microbes Infect; 2003 Apr; 5(5):387-95. PubMed ID: 12737994
[TBL] [Abstract][Full Text] [Related]
6. Growth characteristics of T-cell tropic HIV-1 vpu gene mutants in human peripheral blood mononuclear cells.
Iida S; Fukumori T; Oshima Y; Koyama AH; Adachi A
J Med Invest; 1999 Feb; 46(1-2):43-7. PubMed ID: 10408156
[TBL] [Abstract][Full Text] [Related]
7. Effects of mutant Vpr/Vpx on HIV-2 assembly demonstrated by immunoelectron microscopy.
Wan JJ; Ratner L
Proc Natl Sci Counc Repub China B; 2001 Jan; 25(1):50-8. PubMed ID: 11254173
[TBL] [Abstract][Full Text] [Related]
8. Construction and in vitro properties of SIVmac mutants with deletions in "nonessential" genes.
Gibbs JS; Regier DA; Desrosiers RC
AIDS Res Hum Retroviruses; 1994 May; 10(5):607-16. PubMed ID: 7917522
[TBL] [Abstract][Full Text] [Related]
9. Generation of a chimeric human and simian immunodeficiency virus infectious to monkey peripheral blood mononuclear cells.
Shibata R; Kawamura M; Sakai H; Hayami M; Ishimoto A; Adachi A
J Virol; 1991 Jul; 65(7):3514-20. PubMed ID: 2041078
[TBL] [Abstract][Full Text] [Related]
10. Mutational analysis of simian immunodeficiency virus from African green monkeys and human immunodeficiency virus type 2.
Shibata R; Adachi A; Sakai H; Ishimoto A; Miura T; Hayami M
J Med Primatol; 1990; 19(3-4):217-25. PubMed ID: 2231682
[TBL] [Abstract][Full Text] [Related]
11. Construction and in vitro properties of HIV-1 mutants with deletions in "nonessential" genes.
Gibbs JS; Regier DA; Desrosiers RC
AIDS Res Hum Retroviruses; 1994 Apr; 10(4):343-50. PubMed ID: 8068414
[TBL] [Abstract][Full Text] [Related]
12. The human immunodeficiency virus type 2 vpr gene is essential for productive infection of human macrophages.
Hattori N; Michaels F; Fargnoli K; Marcon L; Gallo RC; Franchini G
Proc Natl Acad Sci U S A; 1990 Oct; 87(20):8080-4. PubMed ID: 2236020
[TBL] [Abstract][Full Text] [Related]
13. Persistent infection of MT-4 cells by human immunodeficiency virus type 1 becomes increasingly likely with in vitro serial passage of wild-type but not nef mutant virus.
Nishino Y; Nakaya T; Fujinaga K; Kishi M; Azuma I; Ikuta K
J Gen Virol; 1994 Sep; 75 ( Pt 9)():2241-51. PubMed ID: 7521392
[TBL] [Abstract][Full Text] [Related]
14. Both virus and host components are important for the manifestation of a Nef- phenotype in HIV-1 and HIV-2.
Ryan-Graham MA; Peden KW
Virology; 1995 Oct; 213(1):158-68. PubMed ID: 7483259
[TBL] [Abstract][Full Text] [Related]
15. Human immunodeficiency virus type 1 vif, vpr, and vpu mutants can produce persistently infected cells.
Nishino Y; Kishi M; Sumiya M; Ogawa K; Adachi A; Maotani-Imai K; Kato S; Hirai K; Ikuta K
Arch Virol; 1991; 120(3-4):181-92. PubMed ID: 1835572
[TBL] [Abstract][Full Text] [Related]
16. Construction and in vitro properties of SIVmac mutants with deletions in "nonessential" genes.
Gibbs JS; Regier DA; Desrosiers RC
AIDS Res Hum Retroviruses; 1994 Apr; 10(4):333-42. PubMed ID: 8068413
[TBL] [Abstract][Full Text] [Related]
17. Comparative analyses of human immunodeficiency virus type 1 (HIV-1) and HIV-2 Vif mutants.
Reddy TR; Kraus G; Yamada O; Looney DJ; Suhasini M; Wong-Staal F
J Virol; 1995 Jun; 69(6):3549-53. PubMed ID: 7745702
[TBL] [Abstract][Full Text] [Related]
18. Cell-free HIV-1Zr6 vif mutants are defective in binding to peripheral blood mononuclear cells and in internalization.
Nagashunmugam T; Friedman HM
DNA Cell Biol; 1996 May; 15(5):353-61. PubMed ID: 8924209
[TBL] [Abstract][Full Text] [Related]
19. Human immunodeficiency virus type 2 vpx protein augments viral infectivity.
Kappes JC; Conway JA; Lee SW; Shaw GM; Hahn BH
Virology; 1991 Sep; 184(1):197-209. PubMed ID: 1714662
[TBL] [Abstract][Full Text] [Related]
20. Human immunodeficiency virus Vpx is required for the early phase of replication in peripheral blood mononuclear cells.
Kawamura M; Sakai H; Adachi A
Microbiol Immunol; 1994; 38(11):871-8. PubMed ID: 7898386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
